Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Covetrus, Inc.
  6. News
  7. Summary
    CVET   US22304C1009

COVETRUS, INC.

(CVET)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Covetrus: 2Q Earnings Snapshot

08/11/2020 | 04:29pm EDT

PORTLAND, Maine (AP) _ Covetrus Inc. (CVET) on Tuesday reported second-quarter net income of $54 million, after reporting a loss in the same period a year earlier.

The Portland, Maine-based company said it had net income of 40 cents per share. Earnings, adjusted for non-recurring gains, came to 19 cents per share.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 8 cents per share.

The animal health technology and services company posted revenue of $1.03 billion in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $900.9 million.

Covetrus shares have risen 75% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $23.09, declining slightly in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CVET at https://www.zacks.com/ap/CVET

Automated Insights, source Associated Press News

All news about COVETRUS, INC.
06/06COVETRUSá : Integrates Prescription and Practice Management Technologies
BU
05/18COVETRUSá : Fonteyne, former CEO of Boehringer-Ingelheim USA, brings 30+ years o..
PU
05/18COVETRUS, INC.á : Change in Directors or Principal Officers, Financial Statement..
AQ
05/18COVETRUSá : Appoints Paul Fonteyne to its Board of Directors
BU
05/17COVETRUS, INC.á : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/07COVETRUS INVESTIGATION INITIATED BY : Kahn Swick & Foti, LLC Investigates the O..
BU
05/07COVETRUSá : Credit Suisse Raises Covetrus' Price Target to $29 from $27, Keeps N..
MT
05/06COVETRUS : Q1 Earnings Snapshot
AQ
05/06COVETRUSá : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
05/06COVETRUSá : Earnings Flash (CVET) COVETRUS Posts Q1 Revenue $1.1B, vs. Street Es..
MT
More news
Financials (USD)
Sales 2021 4 548 M - -
Net income 2021 2,25 M - -
Net Debt 2021 656 M - -
P/E ratio 2021 1 145x
Yield 2021 -
Capitalization 3 650 M 3 650 M -
EV / Sales 2021 0,95x
EV / Sales 2022 0,88x
Nbr of Employees 5 466
Free-Float 75,0%
Chart COVETRUS, INC.
Duration : Period :
Covetrus, Inc. Technical Analysis Chart | CVET | US22304C1009 | MarketScreener
Technical analysis trends COVETRUS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Last Close Price 26,72 $
Average target price 34,60 $
Spread / Average Target 29,5%
EPS Revisions
Managers and Directors
NameTitle
Benjamin C. Wolin President, Chief Executive Officer & Director
Matthew J. Foulston Chief Financial Officer
Philip A. Laskaway Chairman
Georgina Wraight President-Global Technology Solutions & EVP
Steve Palmucci Global Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
COVETRUS, INC.-8.35%3 598
ABBOTT LABORATORIES1.78%198 009
MEDTRONIC PLC7.17%168 902
BECTON, DICKINSON AND COMPANY-3.75%70 038
ALIGN TECHNOLOGY, INC.14.44%48 395
HOYA CORPORATION1.26%48 348